Researcher leverages AI for antimicrobial discovery

VERA Brief

AI-generated. Grounded in the article and its cited sources.

A research lab is using OpenAI's Codex and ChatGPT to analyze genomic data from living and ancient DNA. This AI-driven approach aims to discover new antimicrobial compounds to combat drug-resistant infections.

Key facts

• César de la Fuente's laboratory is using OpenAI's Codex and ChatGPT.
• The research analyzes living and extinct genomes to find antimicrobial molecules.
• The goal is to address the threat of drug-resistant infections.
• AI tools are being used to streamline the drug discovery process.
• This initiative seeks to expand treatments against resistant pathogens.